Should You Buy Sun Life Stock or Manulife Stock?

Top insurance stocks now appear oversold and offer attractive dividend yields.

| More on:
A worker uses a laptop inside a restaurant.

Source: Getty Images

Insurance stocks are down amid the broader market correction. Investors seeking attractive dividends for Tax-Free Savings Account (TFSA) passive income or long-term total returns on a self-directed Registered Retirement Savings Plan (RRSP)are wondering which insurance stocks might be undervalued and good to buy today for a buy-and-hold portfolio.

Sun Life

Sun Life (TSX:SLF) has a current market capitalization of $31 billion. The company operates insurance, wealth management, and asset management businesses primarily in Canada, the United States, and Asia.

Sun Life stock trades near $54 compared to the 2022 high of $74. Investors who buy the shares at the current price can pick up a 5.1% dividend yield.

Sun Life increased the quarterly dividend by 20% late last year from $0.55 per share to $0.66. The board then increased the payout again after the results of the first quarter (Q1) of 2022 to $0.69 per share. These moves suggest the management team isn’t too concerned about the revenue and profits outlook over the next few years, even amid ongoing COVID-19 challenges and the risk of a global recession.

Sun Life generated underlying net income and underlying earnings per share for the first half of 2022 that essentially matched the same period last year. The underlying return on equity slipped from 15.5% to 14.5% but is still strong.

Manulife

Manulife (TSX:MFC) also operates insurance, wealth management, and asset management businesses largely focused on Canada, the United States, and Asia.

The company has a current market capitalization of $40 billion. Manulife stock trades near $21 per share at the time of writing compared to $28 earlier this year. Investors who buy the stock can now get a 6.25% dividend yield.

Manulife generated record profits in 2021. This year has been more difficult due to the impact of the Omicron variant in the first part of 2022 and the plunge in equity markets through Q2 and Q3.

For the first half of 2022, Manulife generated core earnings of $3.1 billion compared to $3.3 billion in the first six months of 2021. Core return on equity dropped to 12% from 13.8% in the same period last year.

Manulife raised the quarterly dividend by 18% late last year to $0.33 per share. The company is also buying back stock with excess funds and repurchased 2% of the outstanding shares in the first two quarters of 2022.

Is one more attractive?

Manulife is generally viewed as a higher-risk pick among the two stocks. The company was forced to slash its dividend by 50% during the Great Recession to protect cash flow due to heavy losses taken on the U.S. variable annuities business. Management has done a good job of reducing market risk from the legacy operations. Earlier this year Manulife completed a deal to reinsure more than 75% of the U.S. variable annuity block at its John Hancock subsidiary. The deal unlocked about $2 billion in capital and meaningfully reduced sensitivity to volatility in equity markets.

Sun Life and Manulife both appear oversold and should be attractive picks for a TFSA or RRSP portfolio. I would probably split a new investment between the two stocks today. If you only choose one, Manulife offers a better dividend yield right now for investors seeking passive income, and the risk of another dividend cut should be very low.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Fool contributor Andrew Walker owns shares of Manulife.

More on Dividend Stocks

Growing plant shoots on coins
Dividend Stocks

2 Under-the-Radar Dividend Payers With Solid Growth Prospects in 2024

These under the radar monthly dividend payers could provide good growth prospects in 2024 and beyond.

Read more »

Question marks in a pile
Dividend Stocks

Should You Buy BMO Stock for its 5.2% Dividend Yield?

BMO stock has outpaced the broader markets in the past two decades. But is this blue-chip TSX bank stock a…

Read more »

data analyze research
Dividend Stocks

Better Dividend Stock for Passive Income: NorthWest REIT or Nexus REIT?

These two dividend stocks offer passive income above 8%, but which is the better (and safer) buy on the TSX…

Read more »

A worker drinks out of a mug in an office.
Dividend Stocks

3 Top Canadian Royalty Stocks With Dividend Yields Averaging 5%

Canadian royalty stocks can provide a lucrative income for investors. Here are three great options to consider buying right now.

Read more »

Pipeline
Dividend Stocks

Is Enbridge Stock a Buy Just for the 7.7% Dividend Yield?

Enbridge is moving higher after a prolonged pullback. Has the stock bottomed?

Read more »

Man considering whether to sell or buy
Dividend Stocks

TD Stock: Buy, Sell, or Hold?

TD stock (TSX:TD) plunged as the company looks to have more expenses on the books for the next year. So…

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Dividend Stocks

These 3 Canadian Dividend Stocks Are a Pensioner’s Best Friend

Consider adding these three TSX dividend stocks to your self-directed retirement portfolio if you want to boost your pension with…

Read more »

dividends grow over time
Dividend Stocks

Earn Passive Income With This 7.6%-Yielding Dividend Stock 

A 7.6% dividend yield is generally opportunistic when dividend stocks are down. But what if you could lock in a…

Read more »